DE | The Delaware Department of Insurance today issued Domestic and Foreign Insurers Bulletin No. 137. The bulletin offers guidance to insurance carriers and pharmacy benefits managers on how to respond to the current national shortage of pediatric antibiotics and ADHD medications. Measures include waiving prior authorization requirements for name-brand medications and allowing the substitution of name-brand drugs for generics if they are not available.
Click here to read the bulletin for additional information.